Why it was recalled
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Product description
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Lot numbers, UPCs & expiration codes
All lots within expiry
Where it was sold
USA nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0388-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Oct 20, 2025
- FDA report date
- Mar 11, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- ANTHONY TRINH, 123Herbals LLC
Original FDA data
Every field from FDA enforcement report D-0388-2026, exactly as published.
Show all FDA fields
- City
- Rosemead
- State
- CA
- Status
- Ongoing
- Country
- United States
- Event ID
- 98258
- Address
- 7214 Berne St
- Code information
- All lots within expiry
- Postal code
- 91770-3844
- Report date
- Mar 11, 2026
- Product type
- Drugs
- Recall number
- D-0388-2026
- Classification
- Class I
- Recalling firm
- ANTHONY TRINH, 123Herbals LLC
- Reason for recall
- Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Distribution pattern
- USA nationwide
- Recall initiation date
- Oct 20, 2025
- Initial firm notification
- Press Release
- Center classification date
- Mar 13, 2026